Literature DB >> 12027530

Cancer: the role of extracellular disease.

L Schwartz1, J Balosso, F Baillet, B Brun, J P Amman, A J Sasco.   

Abstract

Invasive carcinoma originates from the epithelial cells lining the lumen of an organ. It is often preceded by metaplasia, dysplasia or carcinoma in situ. The purpose of this review is to suggest that this disease of the epithelium may be, in part, the result of underlying tissue-based disorganization. Human cancer is frequently associated with pre-existing tissue disease. For example, hepatocellular carcinoma usually occurs in patients with a macronodular cirrhotic liver. Most lung cancers arise among patients with chronic lung disease (bronchitis, emphysema, and chronic infection). Mechanical forces appear to play a major role in regulating normal and cancer cell growth. The loss of cell polarity by neoplastic cells, coupled to an otherwise normal growth rate is enough to explain the cancer star-shaped pattern. By changing the plane of cell division, tumor cells may escape physical constraints from surrounding cells and divide. Loss of cell polarity and the resulting cell proliferation appears to be a consequence of either tissue-based disorganization (chronic inflammation, fibrosis) or of direct carcinogenic insult. The multiple mutations frequently described in cancer may be, in part, secondary to physical stress and not primary events. Several animal and clinical trials have shown that tissue disruption (i.e. radiation-induced fibrosis or liver cirrhosis) can be successfully treated. It is possible that treatment targeted at tissue disruption would delay or reduce cancer incidence regardless of the precise biological mechanism of carcinogenesis. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027530     DOI: 10.1054/mehy.2001.1539

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  8 in total

Review 1.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

2.  A cancer theory kerfuffle can lead to new lines of research.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2014-12-20       Impact factor: 13.506

3.  Synchronous collision malignant melanoma and adenocarcinoma of the rectum.

Authors:  A R Dias; R A Pinto; E Mory; I C Silva; S A C Siqueira; S C Nahas; I Cecconello; S D Wexner
Journal:  Tech Coloproctol       Date:  2010-03-23       Impact factor: 3.781

4.  Squamous cell carcinoma and neuroendocrine carcinoma colliding in the esophagus.

Authors:  André Roncon Dias; Rubens Antonio Aissar Sallum; Nathalia Zalc; Bruno Brito Ctenas; Ulysses Ribeiro; Ivan Cecconello
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 5.  Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling.

Authors:  Martin Jechlinger; Stefan Grünert; Hartmut Beug
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

Review 6.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.

Authors:  Banchob Sripa; Paul J Brindley; Jason Mulvenna; Thewarach Laha; Michael J Smout; Eimorn Mairiang; Jeffrey M Bethony; Alex Loukas
Journal:  Trends Parasitol       Date:  2012-09-01

Review 7.  Mechanical Stress as the Common Denominator between Chronic Inflammation, Cancer, and Alzheimer's Disease.

Authors:  Marcel Levy Nogueira; Jorgelindo da Veiga Moreira; Gian Franco Baronzio; Bruno Dubois; Jean-Marc Steyaert; Laurent Schwartz
Journal:  Front Oncol       Date:  2015-09-17       Impact factor: 6.244

8.  Toward a Reasoned Classification of Diseases Using Physico-Chemical Based Phenotypes.

Authors:  Laurent Schwartz; Olivier Lafitte; Jorgelindo da Veiga Moreira
Journal:  Front Physiol       Date:  2018-02-28       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.